Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Pilot Study | Synapse

⌘+K

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1The Endocannabinoid System and Plant-Derived Cannabinoids in Diabetes and Diabetic ComplicationsReview · 2011 · 153 citations
2An overview of the metabolic effects of rimonabant in randomized controlled trials: potential for other cannabinoid 1 receptor blockers in obesityRCT · 2010 · 99 citations
3Cannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruptionOriginal Research · 2007 · 211 citations
4Cannabinoid-Mediated Modulation of Neuropathic Pain and Microglial Accumulation in a Model of Murine Type I Diabetic Peripheral Neuropathic PainOriginal Research · 2010 · 152 citations
5Cannabidiol Attenuates Cardiac Dysfunction, Oxidative Stress, Fibrosis, and Inflammatory and Cell Death Signaling Pathways in Diabetic Cardiomyopathypreclinical · 2010 · 502 citations
65‐HT<sub>1A</sub>receptors are involved in the cannabidiol‐induced attenuation of behavioural and cardiovascular responses to acute restraint stress in ratsOriginal Research · 2008 · 282 citations
7Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophreniaRCT · 2012 · 1,061 citations
8The diverse CB<sub>1</sub>and CB<sub>2</sub>receptor pharmacology of three plant cannabinoids: Δ<sup>9</sup>‐tetrahydrocannabinol, cannabidiol and Δ<sup>9</sup>‐tetrahydrocannabivarinReview · 2007 · 1,953 citations
9Longitudinal Changes in Exocrine Biomarkers in Children at Risk of Type 1 Diabetes in the ENDIA StudyDiabetes Care · 2026
10Reactions to Race[ism]: The Relationship Between Differential Treatment Based on Race and Diagnosed Diabetes Status in U.S. AdultsDiabetes Care · 2026

More from Diabetes Care

More from University of Nottingham